{"title":"Current Clinical Oncology","description":null,"products":[{"product_id":"cancer-immunotherapy-at-the-crossroads-book-james-h-finke-9781588291837","title":"Cancer Immunotherapy at the Crossroads","description":"Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients' immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells.","brand":"WoB","offers":[{"title":"US \/ GOOD \/ SBYB","offer_id":50384639131921,"sku":"CIN1588291839G","price":0.0,"currency_code":"GBP","in_stock":false},{"title":"US \/ NEW \/ INGRAM","offer_id":51037955981585,"sku":"NIN9781588291837","price":0.0,"currency_code":"GBP","in_stock":false},{"title":"GB \/ NEW \/ INGRAM","offer_id":52674347041041,"sku":"NLS9781588291837","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/1588291839.jpg?v=1751119686"},{"product_id":"integrative-oncology-book-maurie-markman-md-9781588298690","title":"Integrative Oncology","description":"Integrative medicine strives to incorporate the best of complementary and conventional modalities. By examining five prestigious comprehensive cancer centers, the authors focus on the innovative ways in which integrative oncology is being incorporated into conventional cancer care in the United States. The authors discuss the field of integrative oncology, the potential harm and legal issues, and how to communicate concepts and treatment with patients. Integrative Oncology: Incorporating Complementary Medicine into Conventional Cancer Care is a platform from which accomplished professionals describe the various aspects of their programs and present their insights to those seeking to start or improve an integrative oncology program. Integrative oncology is a nascent field, and efforts today are building a rigorous evidenced-based clinical medicine, research, and educational foundation for the future.","brand":"WoB","offers":[{"title":"US \/ GOOD \/ SBYB","offer_id":50384664166673,"sku":"CIN1588298698G","price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/1588298698.jpg?v=1751088374"},{"product_id":"regional-chemotherapy-book-maurie-markman-md-9781468496970","title":"Regional Chemotherapy","description":"Maurie Markman and a panel of distinguished clinicians and leading clinical investigators comprehensively review the current status of regional antineoplastic drug delivery in the management of malignant disease. These authorities present a critical analysis of both the rationale and limitations of regional therapy and discuss potential clinical trials designed to explain the effectiveness of this method of therapy in special settings. Their presentations describe many exciting and innovative strategies for using regional drug delivery in anticancer therapy, including coverage of such areas of special interest as colorectal, skin, lung, pancreatic, ovarian, and gastrointestinal cancers. Comprehensive and authoritative, Regional Chemotherapy: Clinical Research and Practice offers surgical and medical oncologists and clinical cancer investigators a gold-standard review of the current role and future development of this increasingly powerful weapon in the battle against cancer.","brand":"WoB","offers":[{"title":"- \/ - \/ -","offer_id":51028277068049,"sku":"","price":0.0,"currency_code":"GBP","in_stock":true},{"title":"US \/ NEW \/ INGRAM","offer_id":51028280803601,"sku":"NIN9781468496970","price":0.0,"currency_code":"GBP","in_stock":false},{"title":"GB \/ NEW \/ INGRAM","offer_id":52426905649425,"sku":"NLS9781468496970","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/1468496972.jpg?v=1754172633"},{"product_id":"patient-surveillance-after-cancer-treatment-book-frank-e-johnson-9781627039659","title":"Patient Surveillance After Cancer Treatment","description":"Patient Surveillance After Cancer Treatment covers the history of cancer patient surveillance after curative-intent treatment, the rationale, the methodologies used in the past and at present, the methodologies that will probably emerge in the future, the costs of surveillance, the definitions of various terms used in the field, and how those who are interested in the topic can get more information about it from the internet. The secondary focus of the book is to publicize the need for well-designed, adequately powered randomized clinical trials comparing two (or more) surveillance strategies for each type of cancer.  The audience includes all oncologists, cancer researchers, medical economists and policy makers in government and insurance companies, and finally, interested patients.  This book is part of the Current Clinical Oncology series, which provides cutting-edge knowledge of cancer diagnosis, management, and treatment. World renowned experts share their insights in all the major fields of clinical oncology. From the fundamentals of pathophysiology to the latest developments in experimental and novel therapies, Current Clinical Oncology is an indispensable resource for today’s practicing oncologist.","brand":"WoB","offers":[{"title":"US \/ NEW \/ INGRAM","offer_id":51040601735441,"sku":"NIN9781627039659","price":0.0,"currency_code":"GBP","in_stock":false},{"title":"GB \/ NEW \/ INGRAM","offer_id":52137448243473,"sku":"NLS9781627039659","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/1627039651.jpg?v=1751310494"},{"product_id":"palliative-care-book-jane-e-loitman-9781607615897","title":"Palliative Care","description":"A clinical case-based handbook has a role in general clinicians' practice of caring for patients with serious or life-limiting illness. The explosion of the field of Hospice and Palliative Medicine impacts all physicians and healthcare providers. Fellowship trained s- cialists graduate in greater numbers annually. These and more seasoned specialists are now certified by the American Board of Medical Specialties as subspecialists. Research in this field is expanding in scope and quantity, and peer reviewed journals devoted to this work are multiplying. Moreover, peer reviewed journals in primary care and other subspecialties of medicine regularly include papers that focus on end-of-life care, quality of life issues, and symptom management. Overall then, access to clinical information necessary to care for patients with life-limiting illness is not only essential, but also increasingly available. This case-based clinical book aims to help with the actual practice of caring for patients with life-limiting illness. Numerous texts and journals exist to provide the data to inform care, yet there remains a need to find practical points and information about the practical application of the principles of palliative care. Thus, we hope that the cases, key points, and practical tips will help health care providers who are not experts already in palliative care in the care of patients with serious illness and challenging problems. Some chapters follow one patient through the course of an illness to highlight the applicability of palliative care throughout the disease process.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52121128861969,"sku":"NLS9781607615897","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781607615897.jpg?v=1757429250"},{"product_id":"chronic-leukemias-and-lymphomas-book-gary-j-schiller-9781468497328","title":"Chronic Leukemias and Lymphomas","description":"In Chronic Leukemias and Lymphomas: Clinical Management, a panel of recognized experts in hematological oncology describe the unique biological features of indolent hematologic neoplasms, providing powerful insight into their clinical manifestation, highlighting potential targets for novel therapies, and distinguishing these disorders from aggressive lymphoma and Hodgkin's disease. In their integrated surveys of these chronic myeloproliferative and lymphoproliferative disorders, the authors emphasize such unique entities as prolymphocytic leukemias and cutaneous lymphomas. Special emphasis is given to the mechanisms of disease progression with authoritative insights  into the promising new era of antineoplastic pharmacology.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52124851470609,"sku":"NLS9781468497328","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781468497328.jpg?v=1757459732"},{"product_id":"cancer-of-the-lung-book-alan-weitberg-9780896038301","title":"Cancer of the Lung","description":"Alan B. Weitberg, MD, and a panel of internationally recognized basic scientists and clinicians present a comprehensive discussion of lung cancer, including a practice-oriented review of its diagnosis, evaluation, and treatment. The contributors offer not only an understandable description of its molecular origins-an essential key to developing future therapies and preventive measures-but also rigorously discuss well-tested approaches, as well as those that are currently being evaluated for future use in both the laboratory and clinic. The book also elucidates the creation and effective deployment of treatment guidelines introduced by third party payers to improve clinical outcomes, even while lowering healthcare costs.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52127336726801,"sku":"NLS9780896038301","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780896038301.jpg?v=1757485543"},{"product_id":"current-controversies-in-bone-marrow-transplantation-book-brian-j-bolwell-9780896037823","title":"Current Controversies in Bone Marrow Transplantation","description":"Leading transplant physicians critically review and interpret twenty-one key clinical challenges in bone marrow\/hematopoietic cell transplantation, and offer their best personal recommendations for treatment. Topics range from transplant strategies to complications of bone marrow transplantation, including a discussion of the indications, benefits, and the risks for a variety of leukemias, lymphomas, and solid tumors. The authors debate such contentious issues as the appropriateness of transplants in older patients, how many stem cells are sufficient for engraftment, and the pros and cons of umbilical cord blood transplantation. Up-to-date and clinically focused, Current Controversies in Bone Marrow Transplantation offers clinical oncologists, hematology\/oncology fellows in training, and residents in internal medicine today's best ready reference and management guide for all their critical oncologic problems arising from the use of bone marrow\/stem cell transplantation.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52127736430865,"sku":"NLS9780896037823","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780896037823.jpg?v=1757487819"},{"product_id":"regional-chemotherapy-book-maurie-markman-md-9780896037298","title":"Regional Chemotherapy","description":"Maurie Markman and a panel of distinguished clinicians and leading clinical investigators comprehensively review the current status of regional antineoplastic drug delivery in the management of malignant disease. These authorities present a critical analysis of both the rationale and limitations of regional therapy and discuss potential clinical trials designed to explain the effectiveness of this method of therapy in special settings. Their presentations describe many exciting and innovative strategies for using regional drug delivery in anticancer therapy, including coverage of such areas of special interest as colorectal, skin, lung, pancreatic, ovarian, and gastrointestinal cancers. Comprehensive and authoritative, Regional Chemotherapy: Clinical Research and Practice offers surgical and medical oncologists and clinical cancer investigators a gold-standard review of the current role and future development of this increasingly powerful weapon in the battle against cancer.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52133106516241,"sku":"NLS9780896037298","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780896037298.jpg?v=1757526304"},{"product_id":"breast-cancer-book-michael-h-torosian-9780896038394","title":"Breast Cancer","description":"Michael H. Torosian, MD, and a panel of physicians and clinical researchers critically synthesize the wide variety of treatment options available to create a state-of-the-art reference for the management of breast cancer patients. Writing from a multidisciplinary perspective, these authoritative contributors review in the light of the most recent findings the major clinical aspects of breast cancer, including, epidemiology and risk factors, breast imaging, biopsy techniques, breast-conserving surgery and reconstruction, mastectomy, and the latest developments in radiation, hormonal, and chemotherapy. Their expert discussion also addresses special clinical situations (adjuvant chemotherapy, axillary adenopathy as initial presentation, breast cancer during pregnancy, and sarcoma and lymphoma of the breast) and explains current clinical controversies (breast-conserving surgery without radiation therapy, axillary lymph node management, and management of internal mammary lymph nodes).","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52133559304465,"sku":"NLS9780896038394","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780896038394.jpg?v=1757531828"},{"product_id":"intraperitoneal-cancer-therapy-book-c-william-helm-9781627039574","title":"Intraperitoneal Cancer Therapy","description":"Intraperitoneal Cancer Therapy investigates intraperitoneal chemotherapy in a variety of complex and interesting ways. The volume details major clinical trails to date, including immunotherapy, hyperthermic treatment of colo-rectal and ovarian cancers. Authors also examine regional approaches to therapy, systemic therapy, and the use of carboplatin and paclitaxel as the standard treatment for women with stages III and IV ovarian cancer. Other chapters also investigate techniques and procedures in treatment, as well as the future direction of both normothermic and hyperthermic intraperitoneal chemotherapy.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52338787254545,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52338790760721,"sku":"NLS9781627039574","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781627039574.jpg?v=1758169054"},{"product_id":"targeted-cancer-therapy-book-razelle-kurzrock-9781607615989","title":"Targeted Cancer Therapy","description":"Emerging technologies in target identification, drug discovery, molecular markers, and imaging are rapidly changing the face of cancer. This book provides a foundation of knowledge in targeted cancer therapeutics.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52404682785041,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52404683637009,"sku":"NLS9781607615989","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781607615989.jpg?v=1758764855"},{"product_id":"high-grade-gliomas-book-gene-h-barnett-9781588295118","title":"High-Grade Gliomas","description":"This is truly an exciting time in the field of neuro-oncology, particularly in the area of hi- grade gliomas. The management of patients with high-grade gliomas has historically been one of the most challenging and disheartening fields in medicine, where failure is the rule and longevity is the exception. The jaded often state that despite purported advances in surgical and radiotherapeutic techniques and a myriad of clinical trials of medical therapies, the s- vival statistics for glioblastoma have not changed in the last three decades. The nihilism associated with these tumors is such that some practitioners still advise against treatment or even biopsy, recommending palliative care with the diagnosis based only on history and an MRI scan. If the current state-of-the-art in the diagnosis and management of high-grade gliomas was truly so bleak, there would be no reason to compile and publish a monograph on the subject. The fact is that we have recently entered an era where real progress is being made in our understanding and treatment of high-grade gliomas that is directly benefiting some patients. We are slowly but surely chipping away at this problem. One approach has exploited correlations between particular molecular markers and therapeutic response. The first such breakthrough in high-grade glioma was the observation that loss of chromosomes 1p and 19q uniformly predict chemosensitivity in anaplastic oligodendrogliomas (1).","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52431213330705,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52431214182673,"sku":"NLS9781588295118","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781588295118.jpg?v=1759171864"},{"product_id":"colorectal-cancer-book-leonard-b-saltz-9781468496703","title":"Colorectal Cancer","description":"The rapid growth in the number of options available for the management of colorectal cancer presents the clinician with new opportunities and new complexities. An explosion of understanding in the basic science that underlies both the disease and its potential therapies has translated into remarkable technological advances that can now be applied. So many specialties and subspecialties have now been brought to bear that it is appropriate to attempt to bring the expertise from these areas together in one volume, so that practitioners in one aspect of colorectal cancer management can maintain knowledge and expertise regarding the capabilities of other colleagues working in this disease. Colo rectal Cancer: Multimodality Management provides a concise, focused, and current review of the methodological and technological advances that have recently occurred in the management of colorectal cancer. The book has been divided into six basic parts. The first part, dealing with epidemiology and prevention, focuses on the molecular genetic events that occur in the development of colorectal cancer, as well as on our understanding of dietary and environmental factors, and possible strategies for prevention. Part I focuses on both diagnos- tic and therapeutic radiology in the management of colorectal cancer, dealing with innumer- able advances in imaging, and with the progress in the science and art of radiation therapy. The third section deals with the surgical aspects of management of colorectal cancer, starting with surgical pathology.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52431220605201,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52431221391633,"sku":"NLS9781468496703","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781468496703.jpg?v=1759171894"},{"product_id":"chronic-leukemias-and-lymphomas-book-gary-j-schiller-9780896039070","title":"Chronic Leukemias and Lymphomas","description":"In Chronic Leukemias and Lymphomas: Clinical Management, a panel of recognized experts in hematological oncology describe the unique biological features of indolent hematologic neoplasms, providing powerful insight into their clinical manifestation, highlighting potential targets for novel therapies, and distinguishing these disorders from aggressive lymphoma and Hodgkin's disease. In their integrated surveys of these chronic myeloproliferative and lymphoproliferative disorders, the authors emphasize such unique entities as prolymphocytic leukemias and cutaneous lymphomas. Special emphasis is given to the mechanisms of disease progression with authoritative insights  into the promising new era of antineoplastic pharmacology.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52433399775505,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52433400529169,"sku":"NLS9780896039070","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780896039070.jpg?v=1759177857"},{"product_id":"cancer-of-the-lung-book-alan-weitberg-9781617372094","title":"Cancer of the Lung","description":"Alan B. Weitberg, MD, and a panel of internationally recognized basic scientists and clinicians present a comprehensive discussion of lung cancer, including a practice-oriented review of its diagnosis, evaluation, and treatment. The contributors offer not only an understandable description of its molecular origins-an essential key to developing future therapies and preventive measures-but also rigorously discuss well-tested approaches, as well as those that are currently being evaluated for future use in both the laboratory and clinic. The book also elucidates the creation and effective deployment of treatment guidelines introduced by third party payers to improve clinical outcomes, even while lowering healthcare costs.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52453533810961,"sku":"NLS9781617372094","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781617372094.jpg?v=1759368273"},{"product_id":"breast-cancer-book-michael-h-torosian-9781617372162","title":"Breast Cancer","description":"Michael H. Torosian, MD, and a panel of physicians and clinical researchers critically synthesize the wide variety of treatment options available to create a state-of-the-art reference for the management of breast cancer patients. Writing from a multidisciplinary perspective, these authoritative contributors review in the light of the most recent findings the major clinical aspects of breast cancer, including, epidemiology and risk factors, breast imaging, biopsy techniques, breast-conserving surgery and reconstruction, mastectomy, and the latest developments in radiation, hormonal, and chemotherapy. Their expert discussion also addresses special clinical situations (adjuvant chemotherapy, axillary adenopathy as initial presentation, breast cancer during pregnancy, and sarcoma and lymphoma of the breast) and explains current clinical controversies (breast-conserving surgery without radiation therapy, axillary lymph node management, and management of internal mammary lymph nodes).","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52455372718353,"sku":"NLS9781617372162","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781617372162.jpg?v=1759374078"},{"product_id":"colorectal-cancer-book-leonard-b-saltz-9781617377563","title":"Colorectal Cancer","description":"Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and others are in the late phases of clinical development. Likewise, surgical and ablative options, as well as an array of supportive medications, have shown substantial progress and undergone a dramatic proliferation over the past decade. With the increased number of therapeutic options from which to choose, the clinician is better able to offer effective therapy to the patient with colorectal cancer. The clinician is challenged, however, to keep up with the rapidly changing landscape and the rapidly emerging data that shape the options for treatment today and tom- row. In this text, leaders in the management of colorectal cancer review the current literature that has led us to where we are today. Critical evaluations of the data are offered, and evidence-based recommendations are made.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52455395754257,"sku":"NLS9781617377563","price":0.0,"currency_code":"GBP","in_stock":true},{"title":"US \/ NEW \/ INGRAM","offer_id":52752015556881,"sku":"NIN9781617377563","price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781617377563.jpg?v=1759374155"},{"product_id":"integrative-oncology-book-maurie-markman-md-9781617378171","title":"Integrative Oncology","description":"Integrative medicine strives to incorporate the best of complementary and conventional modalities. It examines five prestigious, comprehensive cancer centers based in the US, covering how these centers started their programs, what they are currently doing, and recommendations for starting integrative medicine clinics.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52455688536337,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52455689191697,"sku":"NLS9781617378171","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781617378171.jpg?v=1759375047"},{"product_id":"treatment-of-acute-leukemias-book-ching-hon-pui-9781617372124","title":"Treatment of Acute Leukemias","description":"International experts not only review the state-of-the-art in managing children and adults with acute leukemia, but also debate the pros and cons of current controversial and problematic issues. The book summarizes the best diagnostic and treatment practices for acute leukemias in children, adolescents, and adults. Among the therapies discussed are methotrexate, asparaginase, antipurines, epipodophyllotoxins, hematopoietic stem cell transplantation, hematopoietic growth factors, and immunotherapy.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52455721894161,"sku":"NLS9781617372124","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781617372124.jpg?v=1759375157"},{"product_id":"hepatocellular-carcinoma-book-brian-i-carr-9783319817057","title":"Hepatocellular Carcinoma","description":"•\tHepatocellular carcinoma (HCC) used to be regarded as a rare disease. However, the increasing numbers of chronic HCC carriers in the U.S. and subsequent increased incidences of HCC seen in most large medical centers means that it is no longer an uncommon disease for gastroenterologists or oncologists to encounter and its incidence and epidemiology are changing. During this exciting time in the field of HCC basic science and clinical management, many changes are simultaneously occurring at multiple levels of our understanding and management of the disease. Suddenly, there are several new choices of therapy to offer patients. Hepatocellular Carcinoma, 3rd edition addresses this fast-changing disease and gives the reader a clearer understanding of the many mechanisms involved in carcinogenesis of the liver. This comprehensive and detailed review of how to diagnose and treat hepatocellular carcinoma is written by international leaders in the field, covering both clinical treatment choices and the basic science underlying HCC development. Updated and enhanced from the last edition in 2009, Hepatocellular Carcinoma, 3rd edition features 12 new chapters including discussion of molecular markers, molecular hepatocarcinogenesis, microenvironment, heterogeneity, the new and exciting contributions of immunotherapy, and updates on the major effective hepatitis therapies that will transform HCC incidence and perhaps also the therapy. This cutting-edge text is a vital resource and must-have for today’s hepatologists and medical and surgical oncologists.   \"This is a well written text and should be a good reference book for those who see patients with HCC..\" - Practical Gastroenterology  \"...a useful tool for both physicians and surgeons with a specific interest in the management of patients with HCC.\" - Digestive and Liver Disease","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52479611044113,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52479612190993,"sku":"NLS9783319817057","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9783319817057.jpg?v=1759848963"},{"product_id":"high-grade-gliomas-book-gene-h-barnett-9781617376092","title":"High-Grade Gliomas","description":"This is truly an exciting time in the field of neuro-oncology, particularly in the area of hi- grade gliomas. The management of patients with high-grade gliomas has historically been one of the most challenging and disheartening fields in medicine, where failure is the rule and longevity is the exception. The jaded often state that despite purported advances in surgical and radiotherapeutic techniques and a myriad of clinical trials of medical therapies, the s- vival statistics for glioblastoma have not changed in the last three decades. The nihilism associated with these tumors is such that some practitioners still advise against treatment or even biopsy, recommending palliative care with the diagnosis based only on history and an MRI scan. If the current state-of-the-art in the diagnosis and management of high-grade gliomas was truly so bleak, there would be no reason to compile and publish a monograph on the subject. The fact is that we have recently entered an era where real progress is being made in our understanding and treatment of high-grade gliomas that is directly benefiting some patients. We are slowly but surely chipping away at this problem. One approach has exploited correlations between particular molecular markers and therapeutic response. The first such breakthrough in high-grade glioma was the observation that loss of chromosomes 1p and 19q uniformly predict chemosensitivity in anaplastic oligodendrogliomas (1).","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52481440448785,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52481441431825,"sku":"NLS9781617376092","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781617376092.jpg?v=1759851736"},{"product_id":"biology-and-management-of-multiple-myeloma-book-james-r-berenson-9781617371431","title":"Biology and Management of Multiple Myeloma","description":"Expert physicians and clinical researchers summarize and explain all the recent advances in the biology and treatment of bone marrow-based malignancy. On the biological side, the authors show the characteristics of the malignant cell and describe the significant roles played by oncogenic changes, chromosomal anomalies, Kaposi's sarcoma herpes virus, and cytokines. New epidemiological findings and prognostic factors are also analyzed. On the clinical side, the authors provide a comprehensive review of conventional treatment regimens, as well as a discussion of newer experimental approaches involving immunologic targeting, inhibitors of drug resistance, and antitumor agents.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52481624146193,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52481625260305,"sku":"NLS9781617371431","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781617371431.jpg?v=1759851999"},{"product_id":"squamous-cell-head-and-neck-cancer-book-david-j-adelstein-9781588294739","title":"Squamous Cell Head and Neck Cancer","description":"Leading expert physicians and investigators from around the world review the state-of-the-art in the management of squamous cell head and neck cancer, with emphasis on coordinating different treatment modalities. The authors address several surgical issues, including laser-based surgery, larynx preservation approaches, salvage surgery, and neck management after non-operative treatment. They also discuss definitive radiation for larynx cancer, brachytherapy, altered fractionation radiation, intensity modulated radiation therapy, and the importance of tumor hypoxia, as well as the role of chemotherapy in sequential, concurrent, and adjuvant multi-modality treatment schedules. Other topics of special interest include targeted and gene therapies, multimodality management of nasopharyngeal cancer, chemoprevention, toxicity modification, quality of life outcomes, symptom palliation, and epidemiology.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52483633742097,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52483634659601,"sku":"NLS9781588294739","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781588294739.jpg?v=1759855014"},{"product_id":"molecular-pathology-of-gynecologic-cancer-book-antonio-giordano-9781493956777","title":"Molecular Pathology of Gynecologic Cancer","description":"This book focuses on putting successful molecular strategies into practice for the treatment of gynecologic cancer. It approaches research into the pathology and treatment of gynecologic oncology from both clinical and experimental perspectives. This new volume will be necessary reading for clinicians and experimental researchers alike.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52493354828049,"sku":"NLS9781493956777","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781493956777.jpg?v=1759966808"},{"product_id":"prostate-cancer-book-richard-g-pestell-9781588297419","title":"Prostate Cancer","description":"Award winning authors present a comprehensive review of new perspectives in prostate cancer research and open up new directions in the clinical management of prostate cancer. The authors focus on the biology, genetics, molecular signaling networks in the disease process, and recent advances in the treatment of prostate cancer.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52541837377809,"sku":"NLS9781588297419","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781588297419.jpg?v=1760688273"},{"product_id":"intraoperative-irradiation-book-leonard-l-gunderson-9781493960897","title":"Intraoperative Irradiation","description":"The rationale for using intraoperative irradiation (IORT) is based on the realization that tolerable doses of eternal beam radiation are often insufficient to achieve control of locally advanced malignancies. In these instances, the IORT component of treatment becomes the optimal conformal technique of irradiation, since dose-limiting organs or structures can either be surgically displaced or protected by placement of lead shielding.  This fully revised and expanded second edition is of interest to those with intraoperative electron (IOERT) capabilities, high-dose-rate brachytherapy (HDR-IORT) capabilities, or both. Techniques, indications, and results are discussed by disease site. Each chapter is dual authored by a radiation oncologist and a surgeon, giving a balanced presentation of clinical scenarios. Issues of basic science and physics are also covered, and a notable chapter on normal tissue tolerance is included.  Intraoperative Irradiation: Techniques and Results, Second Edition is a superb compilation, providing essential cutting-edge knowledge. It is a foundation for physicians as IORT develops and becomes more widely available.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52543263441169,"sku":"NLS9781493960897","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781493960897.jpg?v=1760689930"},{"product_id":"lymphoma-book-anas-younes-9781493963171","title":"Lymphoma","description":"Recently, understanding the molecular pathogenesis of malignant lymphomas has led to improvement in the diagnostic precision and to the identification of a variety of molecular therapeutic targets. In addition, new drugs have been approved in the US and Europe, resulting in changes in the standard of care of several types of lymphoid malignancies. Comprehensive in scope and developed by a team of internationally renowned authors, Lymphoma: Diagnosis and Treatment provides a timely update on the most important advances in the biology, diagnosis, and therapy of lymphomas. As part of the Current Clinical Oncology series, Lymphoma: Diagnosis and Treatment will be of value to medical oncologists, hematologists, radiation oncologists, and all physicians involved in the care of patients with lymphoid malignancies.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52586822828305,"sku":"NLS9781493963171","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781493963171.jpg?v=1761055192"},{"product_id":"intraperitoneal-cancer-therapy-book-c-william-helm-9781588298782","title":"Intraperitoneal Cancer Therapy","description":"Intraperitoneal Cancer Therapy investigates intraperitoneal chemotherapy in a variety of complex and interesting ways. The volume details major clinical trails to date, including immunotherapy, hyperthermic treatment of colo-rectal and ovarian cancers. Authors also examine regional approaches to therapy, systemic therapy, and the use of carboplatin and paclitaxel as the standard treatment for women with stages III and IV ovarian cancer. Other chapters also investigate techniques and procedures in treatment, as well as the future direction of both normothermic and hyperthermic intraperitoneal chemotherapy.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52589458456849,"sku":"NLS9781588298782","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781588298782.jpg?v=1761060092"},{"product_id":"colorectal-cancer-book-leonard-b-saltz-9781588297518","title":"Colorectal Cancer","description":"Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and others are in the late phases of clinical development. Likewise, surgical and ablative options, as well as an array of supportive medications, have shown substantial progress and undergone a dramatic proliferation over the past decade. With the increased number of therapeutic options from which to choose, the clinician is better able to offer effective therapy to the patient with colorectal cancer. The clinician is challenged, however, to keep up with the rapidly changing landscape and the rapidly emerging data that shape the options for treatment today and tom- row. In this text, leaders in the management of colorectal cancer review the current literature that has led us to where we are today. Critical evaluations of the data are offered, and evidence-based recommendations are made.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52593178018065,"sku":"NLS9781588297518","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781588297518.jpg?v=1761067329"},{"product_id":"uterine-cancer-book-franco-muggia-9783319472676","title":"Uterine Cancer","description":"For the Editors, the task of writing a Preface is most satisfying. It represents the completion of the book and a moment of reflection on whether the whole is more than the sum of all the parts. And also, one must reflect on how this book is likely to be utilized in this era of rapid communications. The Editors first met in May 2003 at a stimulating Italian symposium on endometrial cancer (organizers Drs. Luigi Frigerio, Roberto Grassi and Andrea Lissoni, with participation of the deans of Italian Gynecologic Oncology, Ugo Bianchi and Constantino Mangioni) that took place at Bergamo and Caravaggio. The impressive gains in biology and clinical trials were further discussed by the two editors and others that are co-authors in this venture on this side of the Atlantic at a 2004 Educational Session at the American Society of Clinical Oncology (ASCO). The pace of progress in various aspects of management of uterine cancer was no- worthy, not only was tumor biology fueling novel hypotheses such as questioning the mesenchymal origin of carcinosarcomas, but knowledge of molecular pathways was beginning to be applied as prognostic and as predictive factors portending benefit from systemic therapies. Surgical staging and sensitive imaging provided the underpinning for refining our treatment algorithms. Finally, a role for che- therapy had finally become established, principally through phase III studies c- paring chemotherapy to radiation in mostly locally advanced stages III and IV that had undergone resection.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52655114322193,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52655114813713,"sku":"NLS9783319472676","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9783319472676.jpg?v=1762219119"},{"product_id":"cancer-immunotherapy-at-the-crossroads-book-james-h-finke-9781468498448","title":"Cancer Immunotherapy at the Crossroads","description":"Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients' immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52662842130705,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52662842982673,"sku":"NLS9781468498448","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781468498448.jpg?v=1762270485"},{"product_id":"lung-cancer-book-david-j-stewart-9781607615231","title":"Lung Cancer:","description":"Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52662955245841,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52662956359953,"sku":"NLS9781607615231","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781607615231.jpg?v=1762270774"},{"product_id":"rectal-cancer-book-brian-g-czito-9781607615668","title":"Rectal Cancer","description":"Rectal Cancer: International Perspectives on Multimodality Management is a timely analysis of the diagnosis, staging, pathology, and therapy of cancer of the rectum. This book is intended as a useful resource for physicians, scientists, medical students, and allied health personnel in the disciplines of radiology, gastroenterology, surgical oncology, medical onc- ogy, radiation oncology, and pathology. Renowned contributors from different medical d- ciplines have written their chapters in a thoughtful, provocative, and visual fashion. Importantly, these chapters highlight the controversies in the diagnostic, staging, and the- peutic management of patients with rectal cancer while providing practical management recommendations. This book is divided into 18 chapters. Early chapters address the diagnosis and staging of rectal cancer, highlighting the critical role of contemporary imaging in guiding treatment. The remaining chapters focus on the multimodality management of rectal cancer from the vantage points of surgery, pathology, chemotherapy, and radiation therapy. The major dev- opments in surgery are reviewed first, including contemporary roles of local excision, total mesorectal excision, lateral pelvic lymph node dissection, organ preservation approaches, as well as the management of advanced, recurrent, and metastatic disease. Following is a ch- ter describing the pathologic evaluation of rectal cancer specimens, with emphasis on proper methodology and its clinical relevance to overall disease management. The final chapters review the contemporary roles of chemotherapy (including with radiation therapy, adjuvant and neoadjuvant settings without radiation therapy, as well as in metastatic disease) as well as radiation therapy (including adjuvant and neoadjuvant approaches, short vs.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52663064396049,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52663065182481,"sku":"NLS9781607615668","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781607615668.jpg?v=1762271045"},{"product_id":"lung-cancer-book-david-j-stewart-9781617796845","title":"Lung Cancer:","description":"Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52665587237137,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52665588121873,"sku":"NLS9781617796845","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781617796845.jpg?v=1762277708"},{"product_id":"targeted-cancer-therapy-book-razelle-kurzrock-9781603274234","title":"Targeted Cancer Therapy","description":"Emerging technologies in target identification, drug discovery, molecular markers, and imaging are rapidly changing the face of cancer. This book provides a foundation of knowledge in targeted cancer therapeutics.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52666374979857,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52666375766289,"sku":"NLS9781603274234","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781603274234.jpg?v=1762279800"},{"product_id":"colorectal-cancer-book-leonard-b-saltz-9780896039353","title":"Colorectal Cancer","description":"The rapid growth in the number of options available for the management of colorectal cancer presents the clinician with new opportunities and new complexities. An explosion of understanding in the basic science that underlies both the disease and its potential therapies has translated into remarkable technological advances that can now be applied. So many specialties and subspecialties have now been brought to bear that it is appropriate to attempt to bring the expertise from these areas together in one volume, so that practitioners in one aspect of colorectal cancer management can maintain knowledge and expertise regarding the capabilities of other colleagues working in this disease. Colo rectal Cancer: Multimodality Management provides a concise, focused, and current review of the methodological and technological advances that have recently occurred in the management of colorectal cancer. The book has been divided into six basic parts. The first part, dealing with epidemiology and prevention, focuses on the molecular genetic events that occur in the development of colorectal cancer, as well as on our understanding of dietary and environmental factors, and possible strategies for prevention. Part I focuses on both diagnos- tic and therapeutic radiology in the management of colorectal cancer, dealing with innumer- able advances in imaging, and with the progress in the science and art of radiation therapy. The third section deals with the surgical aspects of management of colorectal cancer, starting with surgical pathology.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52666777469201,"sku":"NLS9780896039353","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780896039353.jpg?v=1762280857"},{"product_id":"intraoperative-irradiation-book-leonard-l-gunderson-9781617790140","title":"Intraoperative Irradiation","description":"The rationale for using intraoperative irradiation (IORT) is based on the realization that tolerable doses of eternal beam radiation are often insufficient to achieve control of locally advanced malignancies. In these instances, the IORT component of treatment becomes the optimal conformal technique of irradiation, since dose-limiting organs or structures can either be surgically displaced or protected by placement of lead shielding.  This fully revised and expanded second edition is of interest to those with intraoperative electron (IOERT) capabilities, high-dose-rate brachytherapy (HDR-IORT) capabilities, or both. Techniques, indications, and results are discussed by disease site. Each chapter is dual authored by a radiation oncologist and a surgeon, giving a balanced presentation of clinical scenarios. Issues of basic science and physics are also covered, and a notable chapter on normal tissue tolerance is included.  Intraoperative Irradiation: Techniques and Results, Second Edition is a superb compilation, providing essential cutting-edge knowledge. It is a foundation for physicians as IORT develops and becomes more widely available.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52667272528145,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52667273347345,"sku":"NLS9781617790140","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781617790140.jpg?v=1762282134"},{"product_id":"current-controversies-in-bone-marrow-transplantation-book-brian-j-bolwell-9781468498127","title":"Current Controversies in Bone Marrow Transplantation","description":"Leading transplant physicians critically review and interpret twenty-one key clinical challenges in bone marrow\/hematopoietic cell transplantation, and offer their best personal recommendations for treatment. Topics range from transplant strategies to complications of bone marrow transplantation, including a discussion of the indications, benefits, and the risks for a variety of leukemias, lymphomas, and solid tumors. The authors debate such contentious issues as the appropriateness of transplants in older patients, how many stem cells are sufficient for engraftment, and the pros and cons of umbilical cord blood transplantation. Up-to-date and clinically focused, Current Controversies in Bone Marrow Transplantation offers clinical oncologists, hematology\/oncology fellows in training, and residents in internal medicine today's best ready reference and management guide for all their critical oncologic problems arising from the use of bone marrow\/stem cell transplantation.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52670777557265,"sku":"NLS9781468498127","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781468498127.jpg?v=1762290664"},{"product_id":"myeloma-bone-disease-book-g-david-roodman-9781607615538","title":"Myeloma Bone Disease","description":"Multiple myeloma is the second most common hematologic malignancy and c- rently affects approximately 50,000 people in the United States. Each year about 20,000 people are diagnosed with myeloma. Although new treatments have been developed, which signi?cantly prolong the survival of patients, myeloma bone d- ease still remains a major cause of severe morbidity and increased mortality in patients with myeloma. Myeloma bone disease is characterized by punched out lytic lesions caused by increased osteoclastic bone destruction accompanied by suppressed or even absent osteoblast activity. Advances in our understanding of both the pathophysiology of myeloma bone disease and the development of novel agents that target speci?c pathways involved in both the increased osteoclast f- mation and the suppressed osteoblast activity in myeloma provide new hope for these patients. The treatment of myeloma bone disease was revolutionized by cl- ical trials that demonstrated the signi?cant bene't of intravenous bisphosphonate therapy in patients with myeloma bone disease. With the identi?cation of many of the cytokines and chemokines involved in myeloma bone disease, novel th- apies such as denosumab that blocks RANKL activity, anti-DK1, which targets the inhibition of osteoblast activity by blocking Wnt signaling inhibition, and the potential anabolic effects of agents such as bortezomib and activin have greatly improved our potential to block the progression or reverse myeloma bone disease.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52673014726929,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52673015611665,"sku":"NLS9781607615538","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781607615538.jpg?v=1762295998"},{"product_id":"primary-central-nervous-system-tumors-book-andrew-d-norden-9781607611653","title":"Primary Central Nervous System Tumors","description":"This comprehensive, yet practical, text is a ready collection of the most up-to-date information on primary CNS tumors. Authored by a carefully selected group of the world's leading clinicians and scientists, the book is divided into three sections. The opening chapters cover general principles, including epidemiology, pathogenesis, tumor stem cells, supportive care, complications of therapy, and quality of life. The remaining two sections are comprised of treatment-oriented chapters covering the spectrum of gliomas and rarer tumor types. Each of these chapters presents multi-disciplinary therapeutic approaches and addresses specific disease concerns. Throughout, the authors incorporate the cutting-edge advances in molecular biology and genomics that are revolutionizing neuro-oncology. The result is an important clinical resource which provides evidence-based data and interpretation essential to intelligent therapeutic decision making.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52673527578897,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52673528103185,"sku":"NLS9781607611653","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781607611653.jpg?v=1762297297"},{"product_id":"biology-and-management-of-multiple-myeloma-book-james-r-berenson-9780896037069","title":"Biology and Management of Multiple Myeloma","description":"Expert physicians and clinical researchers summarize and explain all the recent advances in the biology and treatment of bone marrow-based malignancy. On the biological side, the authors show the characteristics of the malignant cell and describe the significant roles played by oncogenic changes, chromosomal anomalies, Kaposi's sarcoma herpes virus, and cytokines. New epidemiological findings and prognostic factors are also analyzed. On the clinical side, the authors provide a comprehensive review of conventional treatment regimens, as well as a discussion of newer experimental approaches involving immunologic targeting, inhibitors of drug resistance, and antitumor agents.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52673712914705,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52673713701137,"sku":"NLS9780896037069","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780896037069.jpg?v=1762297762"},{"product_id":"targeted-therapeutics-in-melanoma-book-thomas-f-gajewski-9781617794063","title":"Targeted Therapeutics in Melanoma","description":"Although the cause of most malignant melanomas  over-exposure to ultraviolet light  is well known, effective treatment has remained challenging.  The past several years have been marked by extraordinary developments in melanoma treatment in the arena of targeted therapeutics.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52675007906065,"sku":"NLS9781617794063","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781617794063.jpg?v=1762300922"},{"product_id":"lymphoma-book-anas-younes-9781627034074","title":"Lymphoma","description":"Recently, understanding the molecular pathogenesis of malignant lymphomas has led to improvement in the diagnostic precision and to the identification of a variety of molecular therapeutic targets. In addition, new drugs have been approved in the US and Europe, resulting in changes in the standard of care of several types of lymphoid malignancies. Comprehensive in scope and developed by a team of internationally renowned authors, Lymphoma: Diagnosis and Treatment provides a timely update on the most important advances in the biology, diagnosis, and therapy of lymphomas. As part of the Current Clinical Oncology series, Lymphoma: Diagnosis and Treatment will be of value to medical oncologists, hematologists, radiation oncologists, and all physicians involved in the care of patients with lymphoid malignancies.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52675039133969,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52675039920401,"sku":"NLS9781627034074","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781627034074.jpg?v=1762300991"},{"product_id":"neuroendocrine-tumors-book-james-c-yao-9781603279963","title":"Neuroendocrine Tumors","description":"New research has shown that neuroendocrine tumors are more common than previously thought. Progress in our understanding of the molecular pathogenesis of these not-so-rare cancers has resulted in renewed interest in developing innovative therapeutic options. In particular, novel molecular targeted agents have been shown to have significant anti-tumor activity, and integration of these therapies has led to critical advances in management. In this volume, an outstanding group of the world's leaders in the field have assembled to convey their knowledge of the epidemiology, biology, and management of all the major types of neuroendocrine tumors. The book takes a multi-modality approach to understanding disease processes and therapeutics, including chapters on medical and surgical treatment as well as a chapter devoted to imaging. Throughout, the authors emphasize recent advances in our understanding of molecular biology and the subsequent emerging therapeutic options.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52675092021521,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52675092742417,"sku":"NLS9781603279963","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781603279963.jpg?v=1762301103"},{"product_id":"breast-cancer-in-the-post-genomic-era-book-antonio-giordano-9781603279444","title":"Breast Cancer in the Post-Genomic Era","description":"Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of the mammary gland had greatly increased over the last decade. In Breast Cancer in the Post Genomic Era, Antonio Giordano, Nicola Normanno, and a panel of international authorities in their field provide a comprehensive approach to the biology, diagnosis, prevention, and treatment of human breast carcinoma.   The book provides a comprehensive approach to breast cancer, describing the use of gene profiling techniques to distinguish specific features of individual carcinomas, as well as emerging novel therapeutic approaches to treatment. Additional chapters cover the use of transgenic mice to model human breast cancer and the role of the EGF-CFC family in mammary gland development and neoplasia. Breast Cancer in the Post Genomic-Era succeeds in looking at breast cancer pathogenesis, diagnosis, and treatment under a more comprehensive light, and is a valuable resource for any Radiation or Surgical Oncologist, Cancer Biologist or Pathologist.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52675444408593,"sku":"NLS9781603279444","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781603279444.jpg?v=1762301914"},{"product_id":"melanoma-book-ernest-c-borden-9781468496680","title":"Melanoma","description":"Strategies of treatment involving therapeutic proteins, irnrnune immune cells, or cel- lular protein targets are those of greatest potential for further reducing mortality from melanoma. Therapeutic proteins or cells may inhibit melanoma cell growth either by augmentation of immune cell function or by inhibition of angiogenesis. Cytokines and melanoma antigens may be used either in vivo as a vaccine to stimulate irnrnune immune cell cell function or ex vivo to stimulate or proliferate cells for infusion. Alternatively, alteration in melanoma cell growth can occur through inhibition of protein signal transduction pathways within melanoma cells or in the endothelial cells constituting the necessary angiogenic support for tumor growth. The great promise of these therapies and their cellular targets constitutes the basis for Melanoma: Biologically Targeted Therapeutics. THE CLINlCAL PROBLEM More than four million people will be diagnosed with melanoma in the first decade of the 21st century. Half of those who will die will be individuals who would otherwise have had a life expectancy of another 25 years or more. These individuals will die of systemic systernic metastases, which are present at the time of primary surgery. Despite use of sunscreens, incidence continues to increase in developed countries worldwide. To reduce mortality, there must continue to be a focus on prevention and earlier detection through public education. Early interventions are always preferable to treatment of disseminated metastatic disease.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52675482485009,"sku":"NLS9781468496680","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781468496680.jpg?v=1762302006"},{"product_id":"targeted-therapeutics-in-melanoma-book-thomas-f-gajewski-9781627038768","title":"Targeted Therapeutics in Melanoma","description":"Although the cause of most malignant melanomas - over-exposure to ultraviolet light - is well known, effective treatment has remained challenging.    The past several years have been marked by extraordinary developments in melanoma treatment in the arena of targeted therapeutics.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52675635314961,"sku":"NLS9781627038768","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781627038768.jpg?v=1762302358"},{"product_id":"neuroendocrine-tumors-book-james-c-yao-9781617797569","title":"Neuroendocrine Tumors","description":"New research has shown that neuroendocrine tumors are more common than previously thought. Progress in our understanding of the molecular pathogenesis of these not-so-rare cancers has resulted in renewed interest in developing innovative therapeutic options. In particular, novel molecular targeted agents have been shown to have significant anti-tumor activity, and integration of these therapies has led to critical advances in management. In this volume, an outstanding group of the world's leaders in the field have assembled to convey their knowledge of the epidemiology, biology, and management of all the major types of neuroendocrine tumors. The book takes a multi-modality approach to understanding disease processes and therapeutics, including chapters on medical and surgical treatment as well as a chapter devoted to imaging. Throughout, the authors emphasize recent advances in our understanding of molecular biology and the subsequent emerging therapeutic options.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52675684761873,"sku":"NLS9781617797569","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781617797569.jpg?v=1762302470"},{"product_id":"rectal-cancer-book-brian-g-czito-9781617796951","title":"Rectal Cancer","description":"Rectal Cancer: International Perspectives on Multimodality Management is a timely analysis of the diagnosis, staging, pathology, and therapy of cancer of the rectum. This book is intended as a useful resource for physicians, scientists, medical students, and allied health personnel in the disciplines of radiology, gastroenterology, surgical oncology, medical onc- ogy, radiation oncology, and pathology. Renowned contributors from different medical d- ciplines have written their chapters in a thoughtful, provocative, and visual fashion. Importantly, these chapters highlight the controversies in the diagnostic, staging, and the- peutic management of patients with rectal cancer while providing practical management recommendations. This book is divided into 18 chapters. Early chapters address the diagnosis and staging of rectal cancer, highlighting the critical role of contemporary imaging in guiding treatment. The remaining chapters focus on the multimodality management of rectal cancer from the vantage points of surgery, pathology, chemotherapy, and radiation therapy. The major dev- opments in surgery are reviewed first, including contemporary roles of local excision, total mesorectal excision, lateral pelvic lymph node dissection, organ preservation approaches, as well as the management of advanced, recurrent, and metastatic disease. Following is a ch- ter describing the pathologic evaluation of rectal cancer specimens, with emphasis on proper methodology and its clinical relevance to overall disease management. The final chapters review the contemporary roles of chemotherapy (including with radiation therapy, adjuvant and neoadjuvant settings without radiation therapy, as well as in metastatic disease) as well as radiation therapy (including adjuvant and neoadjuvant approaches, short vs.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52676141252881,"sku":"NLS9781617796951","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781617796951.jpg?v=1762303569"}],"url":"https:\/\/www.worldofbooks.com\/de-de\/collections\/current-clinical-oncology-buchreihe.oembed","provider":"World of Books ","version":"1.0","type":"link"}